Telmisartan and Pomalidomide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Telmisartan (telmisartan) and Pomalidomide (pomalidomide). Common drug interactions include arthralgia among females and asthenia among males.
The phase IV clinical study analyzes what interactions people have when they take Telmisartan and Pomalidomide. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
What is Pomalidomide?
Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.
16 people who take Telmisartan and Pomalidomide together, and have interactions are studied.

What are the common drug interactions of Telmisartan and Pomalidomide, by gender? *:
female:
- Arthralgia (joint pain)
- Back pain
- Blood pressure systolic increased
- Chest pain
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Dry skin
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Heart rate increased
- Muscle spasms (muscle contraction)
male:
- Asthenia (weakness)
- Febrile neutropenia (fever with reduced white blood cells)
- Tongue biting
- Vitamin b12 deficiency
- White blood cell count decreased
- Arthralgia (joint pain)
- Chest pain
- Conjunctival haemorrhage (bleeding underneath the conjunctiva)
- Dyspnoea (difficult or laboured respiration)
- Genital infection fungal
What are the common drug interactions of Telmisartan and Pomalidomide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Arthralgia (joint pain)
- Chest pain
- Muscle spasms (muscle contraction)
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Peripheral coldness
- Plasma cell myeloma (cancer that begins in plasma cells)
- Pulmonary embolism (blockage of the main artery of the lung)
- Rash
- Vision blurred
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 13 people, 81.25%
- Sleep Disorder: 5 people, 31.25%
- Heart Rate Increased: 5 people, 31.25%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 5 people, 31.25%
- Diarrhea: 4 people, 25.00%
- Urinary Tract Infection: 3 people, 18.75%
- N-Terminal Prohormone Brain Natriuretic Peptide Increased: 3 people, 18.75%
- Cytomegalovirus Infection: 3 people, 18.75%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 18.75%
- Dry Eyes (lack of adequate tears): 3 people, 18.75%
* Approximation only. Some reports may have incomplete information.
Do you take Telmisartan and Pomalidomide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Telmisartan (9,163 reports)
- Pomalidomide (14,524 reports)
Browse all drug interactions of Telmisartan and Pomalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pomalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Telmisartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pomalidomide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan and pomalidomide (the active ingredients of Telmisartan and Pomalidomide, respectively), and Telmisartan and Pomalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Piroxicam cause Neurosis? - 7 seconds ago
- Could Ibu cause Thyroglobulin Increased? - 10 seconds ago
- Could Effexor cause Malaise? - 14 seconds ago
- Drug interactions of Oregano and Omeprazole - 15 seconds ago
- Could Actemra cause Tuberculosis? - 16 seconds ago
- Could Ibuprofen cause Heart Rate Irregular? - 23 seconds ago
- Drug interactions of Hytrin and Levothyroxine Sodium - 31 seconds ago
- Could Imodium A-D cause Dry Skin? - 36 seconds ago
- Drug interactions of Letrozole and Nabumetone - 51 seconds ago
- Could Valproic Acid cause Acute Pulmonary Oedema? - 51 seconds ago